Surmodics reported $-79000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3042M 769M
Align Technology ALGN:US $ 294.79M 87.12M
Anika Therapeutics ANIK:US $ 1.24M 1.28M
Arrowhead Research ARWR:US $ -29868000 3.56M
Baxter International BAX:US $ 698M 45M
Bioscrip BIOS:US $ 66.08M 19.27M
Boston Scientific BSX:US $ 839M 198M
Cryolife CRY:US $ 10.72M 1.76M
Edwards Lifesciences EW:US $ 580.3M 158M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Haemonetics HAE:US $ 50.56M 23.84M
Heron Therapeutics HRTX:US $ -59.74M 8.36M
Johnson & Johnson JNJ:US $ 8192M 2043M
Merit Medical Systems MMSI:US $ 39.03M 3.44M
Mesa Laboratories MLAB:US $ 7.69M 1.42M
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Providence Service PRSC:US $ 38.54M 0.13M
Stryker SYK:US $ 1084M 218M
Surmodics SRDX:US $ -0.08M 11.47M
Trinity Biotech TRIB:US 7.09M 3.21M